Who Owns APGE?

Apogee Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$86.42

+0.81 (+0.95%)

Market Cap

$4.8B

Shares Outstanding

55,998,604

Institutional Holders

170

Total Inst. Value

$2.0B

% of Float Held

139.3%

QoQ Holder Change

+53

Institutional data as of Q1 2025

New Positions

36

Closed Positions

21

Increased

51

Decreased

57

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VR Adviser, LLC$317.3M8,493,321
2FMR LLC$280.0M7,493,626
3WELLINGTON MANAGEMENT GROUP LLP$204.9M5,485,754
4BlackRock, Inc.$108.7M2,910,829
5DRIEHAUS CAPITAL MANAGEMENT LLC$87.4M2,339,563
6VANGUARD GROUP INC$77.8M2,082,606
7Fairmount Funds Management LLC$76.5M2,048,647
8MERCER GLOBAL ADVISORS INC /ADV$61.3M1,640,180
9BRAIDWELL LP$57.5M1,540,362
10STATE STREET CORP$49.1M1,313,750

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold APGE?

As of Q1 2025, 170 institutional investors report holding APGE (Apogee Therapeutics, Inc.) in their 13F filings.

What percentage of Apogee Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 139.3% of Apogee Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most APGE?

The largest institutional holder of APGE is VR Adviser, LLC with $317.3M in shares.

Are institutions buying or selling APGE?

This quarter, 36 institutions opened new positions in APGE and 21 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.